Dr. Andrew Jacono on How Video Calls Changed Facelift Demand
OnRemote work did something unexpected to the facial plastic surgery market. It put faces on screens for hours at a time, under high-definition cameras,.
Read MoreEurope’s Deadly Summer Exposes Urban Heat Vulnerability
OnLast summer, southern Europe experienced 23 tropical nights—when temperatures never drop below 20°C—nearly triple the historical average. The consequences were devastating: 24,400 people died.
Read MoreHeather Dixon Appointed CFO at Acadia Healthcare as Company Eyes Major Expansion
OnIn a significant development for Acadia Healthcare Company, Heather Dixon has been appointed as the new Chief Financial Officer (CFO), a move effective from July 10,.
Read MoreBlarcamesine Shows Promising Results in Alzheimer’s Phase 2b/3 Trial
OnAnavex Life Sciences has announced groundbreaking results from its recent Phase 2b/3 clinical trial involving the investigational drug blarcamesine. This trial assessed the drug’s.
Read MoreBlarcamesine Shows Promise in Reducing Alzheimer’s Biomarkers in Phase 2b/3 Trial
OnA recent study by Anavex Life Sciences has unveiled promising results for their investigational Alzheimer’s agent, blarcamesine. The phase 2b/3 trial, conducted across multiple.
Read MoreAnavex Life Sciences Continues to Make Strides in Neurological Research
OnAnavex Life Sciences, a leading pharmaceutical company, continues to make significant advancements in the realm of neurological research. Through their unwavering commitment to innovate,.
Read More